Frank Mottola, Senior VP, Quality, GMP Oper. & IT at SUPERNUS PHARMACEUTICALS, INC. (SUPN), sold 9,560 shares at $35.99 ($344K) on 2023-03-14, disclosed to the SEC on 2023-03-16.
Open-market sale of $344k SUPN by Senior VP, Quality, GMP Oper. & IT. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.99 | 4,780 | $172K | 50.0% |
| 2 | $35.99 | 4,780 | $172K | 50.0% |
| Total | $35.99 avg | 9,560 | $344K | 100% |
| Filing → |
| SUPN | SELL | 2025-09-15 | $229K | — | Filing → |
| SUPN | SELL | 2025-08-27 | $623K | — | Filing → |
| SUPN | SELL | 2024-11-08 | $555K | — | Filing → |